Dynamic Pharma

What Dynamic Pharma does

Dynamic Pharma Group is a privately-held pharmaceutical services company headquartered in Orlando, Florida, operating since 1994 with a lean team of 1-10 employees. The company runs a Licensing, Acquisition & Commercialization (LAC) division that supports international pharmaceutical and biotechnology companies seeking to enter Latin American markets. Its offering is structured around three interconnected service pillars: (i) Licensing & Acquisition Services, which sources product opportunities and structures partnership deals; (ii) Regulatory Affairs & Registration Services, which manages submissions and approvals with health authorities across Latin America including ANVISA (Brazil), INVIMA (Colombia), and COFEPRIS (Mexico); and (iii) Commercialization & Market Access Services, which executes launches via tailored go-to-market strategies, distribution partnerships, and pricing/reimbursement negotiations.

The company has no proprietary technology platform; it is a relationship-driven services intermediary whose core asset is human expertise in LATAM regulatory pathways and local market access. Revenue is generated through licensing royalties, deal-facilitation fees, regulatory service fees, and commercialization engagements — pricing is not publicly disclosed and engagements appear quote-based. Its go-to-market is sales-led via direct email outreach ([email protected]) targeting pharma and biotech licensing decision-makers.

The firm operates independently with no parent company, no institutional investors, no disclosed funding rounds, no M&A history, and no named management team. Customer logos are not disclosed, and revenue figures are unavailable. The competitive position rests on claimed regulatory expertise and distribution partnerships across LATAM, with no certifications, patents, or industry awards documented.

Name

Dynamic Pharma

Legal name

Dynamic Pharma Group

Website

https://dynamicpharma.net

Company type

Private

Founded year

1994

Operating status

Operating

Headcount range

1–10 employees

Short description

Dynamic Pharma Group is a privately-held pharmaceutical services firm in Orlando, Florida, helping international pharma and biotech companies license, register, and commercialize products across Latin American markets including Brazil, Colombia, and Mexico.

Ownership category

akta.pro rank

Product category

Pharmaceutical Services

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (424210), Wholesale Trade Agents and Brokers (4251)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Channel & Trade Strategy (Gross-to-Net, Distribution Economics) (HLAIAKAI)

akta.pro secondary industries

Access Policy, Advocacy & Stakeholder Management (HLAIAKAL), Global Supply Chain, Procurement & Market-Shaping Partnerships (Medicines/Diagnostics/Vaccines) (HLAJAOAK)

Keywords

• Pharmaceutical licensing
• Regulatory affairs services
• Pharmaceutical commercialization
• Market access services
• LATAM pharmaceutical distribution

Headquarters

HQ city

Seaside

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

1. Licensing and Acquisition Services: The company generates revenue through licensing partnerships and acquisition support for pharmaceutical and biotech products entering Latin American markets. Revenue is derived from facilitating deal execution, regulatory approvals, and commercialization activities.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Core offering

Dynamic Pharma Group's Licensing, Acquisition & Commercialization (LAC) Division supports international pharmaceutical and biotech companies in establishing a presence across Latin America. The company identifies promising product opportunities, forms strategic licensing partnerships, manages regulatory submissions with regional health authorities (ANVISA in Brazil, INVIMA in Colombia, COFEPRIS in Mexico), and executes product launches through tailored go-to-market strategies, distribution partnerships, and market access specialists who secure pricing, reimbursement, and formulary inclusion.

Product overview

Dynamic Pharma is a service-based company offering a unified suite of pharmaceutical licensing, acquisition, and commercialization services for Latin American markets. The portfolio consists of three interconnected service pillars: (1) Licensing & Acquisition Services, which identifies product opportunities and forms strategic partnerships; (2) Regulatory Affairs & Registration Services, which manages regulatory submissions across Latin American health authorities (ANVISA, INVIMA, COFEPRIS); and (3) Commercialization & Market Access Services, which handles product launches, distribution, and market penetration strategies. Together, these services support international pharmaceutical and biotech companies in establishing a successful presence across Latin America.

Differentiator

Problem solved

Functional benefit

Products and services

• Licensing & Acquisition Services Identifies promising pharmaceutical and biotech product opportunities and forms strategic licensing partnerships with innovative companies worldwide; facilitates deal execution for out-licensing or market expansion into Latin America.
• Regulatory Affairs & Registration Services Manages the entire regulatory submission and approval process with health authorities across Latin America, including ANVISA (Brazil), INVIMA (Colombia), and COFEPRIS (Mexico); ensures timely approvals and local compliance.
• Commercialization & Market Access Services Launches and promotes products using tailored go-to-market strategies, commercial infrastructure, and distribution partnerships; market access specialists secure favorable pricing, reimbursement, and formulary inclusion across Latin America.

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• Unnamed Distribution PartnerscoreChannel Partner/ Reseller/ DistributorDistribution partnerships with local distributors across Latin American markets to enable product launch, distribution, and market access. These partnerships form a core component of Dynamic Pharma's commercialization infrastructure for reaching patients across the region.

Scale indicators1 record

Recent moves4 records

Expansion highlights5 records

Broad incumbents

• Eurofarma: One of the largest Brazilian pharmaceutical manufacturers with extensive LATAM distribution and commercialization infrastructure. Overlaps with Dynamic Pharma's commercialization and market-access offering, but at much greater scale and as part of a broader manufacturing-led portfolio.
• ICON plc: Global clinical research and drug development services organization with significant LATAM operations. Competes with Dynamic Pharma on the regulatory affairs and drug-development support side of the value chain at a much larger scale.
• IQVIA: Global leader in clinical research, regulatory, and commercial services to the pharmaceutical industry with substantial LATAM presence. Competes with Dynamic Pharma on the regulatory and market-access service pillars, but at vastly larger scale as part of a global services platform.
• Syneos Health: Global biopharmaceutical services organization offering clinical and commercial solutions including regulatory and market access across LATAM. Comparable in offering commercialization and regulatory support, though as part of a much broader CRO/services portfolio.

Regional players

• Genomma Lab: Mexican pharmaceutical company focused on OTC and personal care products with broad LATAM market reach. Comparable as a LATAM-anchored pharma commercialization operator, though primarily a brand owner rather than a licensing intermediary.
• Aché Laboratórios: Major Brazilian pharmaceutical manufacturer with growing international presence across Latin America. Comparable in operating across the same regional pharma landscape, though primarily as a manufacturer rather than a licensing intermediary.
• Tuteur: Argentine pharmaceutical company with international operations across Latin America. Comparable as a regional LATAM pharma operator with licensing and distribution capabilities, though primarily Argentina-anchored rather than US-based.
• Biolab Farmacêutica: Brazilian pharmaceutical manufacturer with a focus on innovation and international expansion across Latin America. Comparable as a regional pharma operator building presence across LATAM markets, though primarily through proprietary products rather than as a licensing partner.

Direct peers

• PharmaLex (Cencora): Global pharmaceutical regulatory affairs, market access, and consulting services provider serving companies seeking product approvals across multiple jurisdictions. Highly comparable to Dynamic Pharma's regulatory and market-access service pillars, though operating at substantially larger scale globally.
• Moksha8: Brazil-based specialty pharmaceutical company focused on licensing, distribution, and commercialization of innovative therapies across Latin America. Directly comparable to Dynamic Pharma in serving international pharma companies seeking LATAM market entry through licensing and partnership models.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

• Xx.com/DynamicPharma
• LinkedInlinkedin.com/company/dynamic-pharma-group

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Dynamic Pharma